In a study comparing the effects of semaglutide and tirzepatide for weight loss, those receiving tirzepatide were more likely to achieve 5% or greater, 10% or greater, and 15% or greater weight loss and experienced larger reductions in body weight at 3, 6, and 12 months
Keep track of your menstrual patterns and be conscious of your body's reactions as you continue with semaglutide therapy
Glucose, A1C, kidney markers, electrolytes, liver-related tests, lipids, and selected nutritional biomarkers can provide objective information about treatment response and possible complications
Low protein leads to muscle loss, which lowers metabolic rate, which slows weight loss
GLP-1 medications commonly cause nausea, especially early on
Collectively, this indicates a role for CNS GLP-1R populations to mediate food intake suppression by pharmacologic, and to a lesser degree physiologic, GLP-1R agonism